NDLI: Benefits of continuous glucose monitor use in clinical practice.

Please wait, while we are loading the content...

Addison disease presenting with acute neurologic deterioration: a rare presentation yields new lessons from old observations in primary adrenal failure.

Decreased calcitriol requirement during pregnancy and lactation with a window of increased requirement immediately post partum.

What is the diagnosis? Acromegaly.

Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvement.

Multiple paraganglioma syndrome type 4 due to succinate dehydrogenase B mutation: diagnostic and therapeutic challenges of a skull base paraganglioma masquerading as nasopharyngeal cancer.

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

Paradoxical severe decrease in high-density lipoprotein cholesterol due to rosiglitazone-fenofibrate interaction.

Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole.

Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.

Effect of a diabetes curriculum on internal medicine resident knowledge.

Serum matrix metalloproteinase-9 levels in the diagnosis of functioning adrenal tumors.

Computerized physician order entry- based hyperglycemia inpatient protocol and glycemic outcomes: The CPOE-HIP study.

Color-flow doppler sonography in patients with subclinical thyroid dysfunction.

Papillary thyroid carcinoma metastatic to skin may herald aggressive disease.

Managing diabetes in the heat: potential issues and concerns.

Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.

Vitamin D role and use in prediabetes.

State-of-the-art inpatient diabetes care: the evolution of an academic hospital.

Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the american thyroid association, american association of clinical endocrinologists, and the endocrine society.

Benefits of continuous glucose monitor use in clinical practice.

Year: 2010 Volume: 16 Issue: Supplementary 3

Year: 2010 Volume: 16 Issue: 2

Year: 2010 Volume: 16 Issue: 1

Year: 2010 Volume: 16 Issue: Supplementary 1

Year: 2009 Volume: 15

Year: 2008 Volume: 14

Year: 2005 Volume: 11

Year: 2004 Volume: 10

Benefits of continuous glucose monitor use in clinical practice.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Leinung, Matthew Thompson, Shannon Nardacci, Elizabeth
Description	Country affiliation: United States Author Affiliation: Leinung M ( Division of Endocrinology, Albany Medical College, Albany, New York 12208, USA. einunm@mail.amc.edu)
Abstract	OBJECTIVE: To determine the benefits of personal continuous glucose monitoring (CGM) outside of a controlled clinical trial in a single ambulatory diabetes clinic. METHODS: In this retrospective study, we reviewed medical records of all patients who began CGM in our university-based clinical practice between July 2006 and October 2008. Data pertaining to 1 year before initiation of CGM through January 2009 were collected. All patient visits were performed by any 1 of 7 board-certified endocrinologists and/or 5 certified diabetes educators. A severe hypoglycemic event was considered to have occurred if the patient reported requiring assistance or losing consciousness, or if there was documentation from another source (eg, an emergency department visit). Analysis of the effect of CGM on hemoglobin A1c and occurrence of severe hypoglycemia was performed. RESULTS: A total of 117 patients initiated CGM between July 2006 and October 2008 and used CGM for at least 2 months (total experience on CGM, 1136 patient-months; average 9.7 months per patient). Mean age was 44.5 +/- 12.8 years (range, 14.3-71.7 years), and average duration of diabetes mellitus was 23.9 years. All patients were using insulin pumps before initiation of CGM, including 10 patients with type 2 diabetes. Sixty-eight patients (58%) had preexisting hypoglycemia unawareness. Average hemoglobin A1c level for 1 year before CGM initiation was 7.6 +/- 1.1%, and with CGM use it dropped to 7.2 +/- 0.8% (P<.001). Forty-two patients had severe hypoglycemic events in the year before CGM use or during CGM use. Overall, CGM use was associated with a significant decrease in the rate of severe hypoglycemic episodes (odds ratio, 0.40; 95% confidence interval, 0.24-0.65). CONCLUSIONS: Personal CGM, in a real-world setting, improves glucose control and reduces the rate of severe hypoglycemic episodes.
File Format	HTM / HTML
ISSN	1530891X
Issue Number	3
Volume Number	16
e-ISSN	19342403
Journal	Endocrine Practice
Language	English
Publisher	American Association of Clinical Endocrinologists
Publisher Date	2010-05-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Endocrinology Blood Glucose Analysis Diabetes Mellitus Blood Adolescent Adult Aged Blood Glucose Self-monitoring Metabolism Female Hemoglobin A, Glycosylated Humans Hypoglycemia Male Middle Aged Odds Ratio Retrospective Studies Young Adult Journal Article Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Endocrinology, Diabetes and Metabolism Endocrinology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

Does availability of reliable home blood glucose data at diabetes appointments improve glycemia?

Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya.

Hemoglobin A1C, mean glucose, and persistence of glycation ratios in insulin-treated diabetes.

Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study.

Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.

Diabetes and driving.

Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring.

Benefits of continuous glucose monitor use in clinical practice.

Similar Documents

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

Does availability of reliable home blood glucose data at diabetes appointments improve glycemia?

Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya.

Hemoglobin A1C, mean glucose, and persistence of glycation ratios in insulin-treated diabetes.

Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study.

Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.

Diabetes and driving.

Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring.

Benefits of continuous glucose monitor use in clinical practice.